Walking with controlled breathing improves exercise tolerance, anxiety, and quality of life in heart failure patients: A randomized controlled trial

European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology
Hsiu-Chin TengMei-Hua Wang

Abstract

Patients with heart failure experience not only impaired physical condition, but also their physical activity, moods, and quality of life may be diminished. The purpose of this study was to investigate the effects of 12-week walking with breathing program on physical activity tolerance considering time-dependent physiological factors and time-independent interoceptive awareness, as well as psychosocial factors. This randomized controlled trial recruited 90 heart failure patients and randomly assigned them. The walking with breathing group received the walking and breathing intervention for 12 weeks but the control group did not. Outcomes included activity tolerance measured by 6-minute walk distance, moods assessed by the Hospital Anxiety and Depression Scale, quality of life determined by the EuroQol 5-Dimensions, oxygen saturation by pulse oximetry, and interoceptive awareness by the Multidimensional Assessment of Interoceptive Awareness scale. Data were collected before the intervention at baseline and at Weeks 2, 4 and 12. The results of the generalized estimating equation showed the 6-minute walk distance in the walking with breathing group was significantly different across time ( p<0.001) compared with the control group ...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Apr 13, 2004·Journal of Rehabilitation Medicine·Georgia KoukouvouAsterios Deligiannis
Sep 8, 2006·Progress in Cardiovascular Nursing·Elizabeth GunnHeather M Arthur
May 15, 2009·PloS One·Wolf E MehlingAnita Stewart
Jul 21, 2009·Primary Care Companion to the Journal of Clinical Psychiatry·Jeffrey A CullyAnita Deswal
Aug 4, 2009·Research in Nursing & Health·Corrine Y JurgensUNKNOWN Heart Failure Quality of Life Trialist Collaborators
Sep 8, 2009·Internal Medicine Journal·T RasekabaA E Holland
Jan 30, 2010·Health and Quality of Life Outcomes·Matthew T D DyerMartin J Buxton
Feb 18, 2011·Archives of Internal Medicine·Sherry L GraceUNKNOWN Cardiac Rehabilitation Care Continuity Through Automatic Referral Evaluation (CRCARE) Investigators
Feb 22, 2012·Journal of Physiotherapy·Carrie Ritchie
Mar 1, 2012·Frontiers in Human Neuroscience·Adam MoorePeter Malinowski
Nov 8, 2012·PloS One·Wolf E MehlingAnita Stewart
Nov 22, 2012·European Journal of Preventive Cardiology·Annett SalzwedelHeinz Völler
Mar 21, 2013·Circulation. Heart Failure·Amanda R MoraskaVéronique L Roger
Mar 15, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Roxane Raffin ChanJanet L Larson

❮ Previous
Next ❯

Citations

Jun 17, 2020·The Journal of Cardiovascular Nursing·Ruth Taylor-Piliae, Brooke A Finley
Mar 3, 2020·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Philip Moons
Feb 7, 2021·Journal of Clinical Medicine·Aliyah SnyderRobert Asarnow
Apr 15, 2021·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Bing-Jun HsiehChia-Yu Chu

❮ Previous
Next ❯

Software Mentioned

power
SPSS
EuroQol

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.